ArticleTherapeutic advances in medical oncology2026
Real-world outcomes of FOLFIRINOX versus gemcitabine plus nab-paclitaxel and prognostic factors in advanced pancreatic cancer: a retrospective cohort study.
Carlos Escriva-Aranda et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.